ArticleCase reports in hematology2022

Bortezomib Use for a Critically Ill Patient with Angioimmunoblastic T-Cell Lymphoma.

Motoharu ShibusawaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.